在过去的二十年里,宫癌生存率的全球研究趋势:图书识别分析
Syed S Abrar1, Suhaily Mohd Hairon1, Najib Majdi Yaacob2
1Department of Community Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.
The Malaysian journal of medical sciences : MJMS
|January 20, 2025
概括
本文献分析揭示了宫癌存活率的全球研究趋势,确定了关键贡献者和研究热点. 需要进一步调查,特别是在低收入和中等收入国家.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 图书统计学 图书统计学
背景情况:
- 子宫癌是全球主要的健康问题,特别是在低收入和中等收入国家.
- 通过癌症登记处跟踪患者的生存率对于有效的癌症管理至关重要.
- 之前的文献计量研究集中在宫癌的炎症和放射治疗上,但生存分析的研究趋势仍然未被探索.
研究的目的:
- 对全球研究趋势和宫癌存活率的热点进行文献计量分析.
- 确定这个研究领域的领先国家,机构和作者.
- 提供关于宫癌生存研究的演变和模式的见解.
主要方法:
- 使用Web of Science核心集合 (WoSCC) 数据库进行了系统的文献搜索.
- 搜索术语包括"生存" (和变异) 与"宫癌" (和变异) 相结合.
- 数据分析利用WoSCC工具和VOSviewer来检查研究趋势,合作和有影响力的出版物.
主要成果:
- 在2000年至2023年期间,共发表了840篇关于子宫癌存活率的论文.
- 中国人民共和国和美国是最多产的贡献者,占出版物的50%.
- 研究涉及4,759名作者,1,454个机构和82个国家,在过去十年中出现了显著的增长.
结论:
- 在过去的十年中,全球关于子宫癌存活率的研究大幅增加.
- 虽然领先的国家占主导地位,但在高风险地区,特别是低收入和中等收入国家,急需刺激和支持研究.
- 进一步的研究对于改善全球宫癌患者的理解和结果至关重要.
关键词:
在VOSviewer中使用VOSviewer.圣经计量资料 (Bibliometric bibliometric bibliometric) 是指参考书目中的资料.宫癌:子宫癌是一种癌症.幸存率 幸存率 生存率更多相关视频
07:50Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
08:57Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies
Published on: September 19, 2025
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:30Current Trends in Nursing II
Trends in nursing are multifactorial and associated with changes in society, within the nursing profession, and in other professions. Notably, telehealth and remote nursing contribute to successful healthcare delivery for numerous patients and help reduce stress for nurses due to nursing shortages. Nurses can reach patients, monitor their conditions, and interact with them using computers, audio, visual accessories, and telephones—for example, remote patient monitoring systems. Likewise,...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...